Answers are grounded in this paper and cite their sources.
Alzheimer's disease (AD) stands out as one of the most devastating and prevalent neurodegenerative disorders known today. Researchers have identified several enzymatic targets associated with AD among which Glycogen synthase kinase-3β (GSK-3β) and Acetylcholinesterase (AChE) are prominent ones. Unfortunately, the market offers very few drugs for treating or managing AD, and none have shown significant efficacy against it.
No takes yet. Share an insight, caveat, or question.
Londhe et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: